What is ABBV stock price today?

ABBV (AbbVie Inc) stock is trading at $244.78 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is ABBV stock going up or down today?

ABBV stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy ABBV stock now?

The decision to buy ABBV depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is ABBV a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for ABBV based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is ABBV stock overvalued or undervalued?

ABBV currently trades at a P/E ratio of 80.54, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if ABBV is fairly priced.

What is ABBV's P/E ratio?

ABBV has a price-to-earnings (P/E) ratio of 80.54, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is ABBV's market cap?

ABBV (AbbVie Inc) has a market capitalization of $334.34 billion, making it a large-cap stock.

What is ABBV's price to book ratio?

Price-to-book ratio for ABBV is available on our dashboard along with other valuation metrics.

Does ABBV pay dividends?

Yes, ABBV pays dividends with a current yield of 3.53%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is ABBV's dividend yield?

ABBV's dividend yield is 3.53%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is ABBV stock a good long-term investment?

ABBV's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is ABBV's revenue growth rate?

Revenue growth data for ABBV is available on our dashboard with detailed financial statement analysis.

Profitability metrics for ABBV are available on our dashboard with complete income statement analysis.

What are the risks of investing in ABBV?

Key risks for ABBV include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does ABBV compare to its competitors?

Compare ABBV to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ABBV's performance and positioning.

What is ABBV's stock price target for 2026?

Our AI model provides price targets for ABBV based on fundamental analysis: Bull case $318.21 (+30%), Base case $281.50 (+15%), Bear case $220.30 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about ABBV?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for ABBV. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is ABBV's next earnings report?

ABBV reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

ABBV - AbbVie Inc

NYSE * Healthcare * Drug Manufacturers - General

$244.78

$-3.22 (-1.30%)

About AbbVie Inc

AbbVie Inc (ABBV) common stock

Price Chart

Loading chart...

ABBV Key Statistics

Market Cap

$334.34B

P/E Ratio

80.54

Dividend Yield

3.53%

How ABBV Compares to Peers

ABBV trades at a premium valuation vs peers (highest P/E)

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
ABBV(This stock)	$334.34B	80.5	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
BMYBristol-Myers Squibb	$95.36B	17.5	0%	0.0%	vs BMY

Data Updated: July 15, 2026 at 6:10 AM EDT

Ready to invest in ABBV?

Commission-free trading available. Affiliate links.

ABBV Lician Score

14% confidence

5.0/10

Neutral

ABBV has a Lician Score of 5/10 (Average). Strengths: Quality. Areas of concern: Growth.

value

5.0

growth

3.0

quality

8.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates ABBVacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

ABBV Financial Snowflake

5-axis analysis across key investment dimensions

5.2/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

8.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for ABBV

Dashboard

Enter a ticker to analyze